GPT and type 2 diabetes mellitus: Whilst both group of patients had comparable door-balloon time (Fig. 1C), T2D patients had significantly higher markers of myocardial damage such as circulating troponin (Fig. 1D) and plasma markers which are known to correlate with poorer ACS outcomes—increased plasma leukocytes, ALT and lower Mg (Table 2).